| 研究生: |
劉香君 Liu, Hsiang-Chun |
|---|---|
| 論文名稱: |
印刷作業勞工鄰苯二甲酸酯類暴露評估研究 Exposure assessment of phthalate esters for workers in printing industry |
| 指導教授: |
李俊璋
Lee, Ching-Chang |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 環境醫學研究所 Department of Environmental and Occupational Health |
| 論文出版年: | 2011 |
| 畢業學年度: | 99 |
| 語文別: | 中文 |
| 論文頁數: | 106 |
| 中文關鍵詞: | 鄰苯二甲酸酯類 、職業暴露 、生物偵測 、印刷業 、荷爾蒙 |
| 外文關鍵詞: | Phthalate esters, Occupational exposure, Biological monitoring, Printing industry, Hormone |
| 相關次數: | 點閱:137 下載:5 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
鄰苯二甲酸酯類 (phthalate esters, PAEs)具有良好的油溶性,可添加於印刷油墨中做為分散劑,降低色料碳粒之聚集,達到印刷製品顏色分佈均勻之目的,印刷作業現場勞工可能經由呼吸吸入、皮膚吸收等途徑,暴露過量之PAEs粉塵與蒸氣,進而引起相關之健康危害。本研究目的為針對印刷業勞工進行PAEs暴露評估,並探討PAEs暴露對於生殖荷爾蒙、甲狀腺荷爾蒙之影響。研究對象選自兩間中型印刷廠,女性及男性人數分別為20與31人,每位勞工均進行個人呼吸區空氣濃度採樣與分析、個人血液生殖及甲狀腺荷爾蒙分析、上下班前尿液PAEs代謝物分析、個人生活與職場時間活動模式問卷調查。以職稱與可能暴露濃度劃分組別,高暴露組(現場作業、包裝人員)共34人,低暴露組(辦公行政、美工人員)共17人。研究結果顯示,在男性勞工中,高暴露組(現場作業、包裝人員)與低暴露組(辦公室行政、巡廠人員)之空氣中DEHP濃度(0.5 μg/m3 vs 0.3 μg/m3, p<0.05),以及下班前尿中MBP濃度(94.8 μg/g-Cre vs. 67.6 μg/g-Cre, p<0.05)皆達顯著差異。此外,再比較下班前與上班前之尿中PAEs代謝物濃度,於高暴露組男性勞工中,亦觀察到顯著之差異情形:MBP (94.8 μg/g-Cre vs. 66.6 μg/g-Cre, p<0.05)、MEHP (14.0 μg/g-Cre vs. 5.9 μg/g-Cre, p<0.05)、 MEOHP (39.0 μg/g-Cre vs. 15.9 μg/g-Cre, p<0.05)、MEHHP (85.4 μg/g-Cre vs. 32.7 μg/g-Cre, p<0.05)、MECPP (69.7 μg/g-Cre vs. 27.9 μg/g-Cre, p<0.05),表示現場作業勞工確實有較明顯之職業暴露。進一步以用空氣PAEs之濃度(Daily Intake, DI Air)及尿液中PAEs代謝物濃度推估PAEs日攝取劑量 (Daily Intake, DI Urine),結果顯示,高暴露組勞工之DEHP DI Air(0.03 μg/kg/day vs. 0.02μg/kg/day, p<0.05)及DBP DI Urine(4.3μg/kg/day vs. 3.0μg/kg/day, p<0.05)顯著高於低暴露組。空氣濃度與尿液中代謝物濃度之相關性,高暴露組男性勞工空氣中DEHP濃度與尿液中MEOHP、MECPP濃度皆達統計上顯著相關 (p<0.05),相關係數為分別為0.4930及0.5696,可知印刷作業場所中空氣暴露係為勞工PAEs之暴露途徑之一。以尿液中PAEs代謝物中位數濃度分組時,高濃度組平均DBP及DEHP DISkin佔總攝取量之66.2 %及63.7 %,顯示皮膚吸收對於印刷業勞工而言,其重要性遠較呼吸吸入途徑為高。計算其勞工經由空氣之暴露危害指標,計算高、低濃度組經由空氣中DBP及DEHP之危害指標,以U.S. EPA和EFSA為參考劑量標準時,全體勞工經由空氣中PAEs濃度所計算而得HI值皆遠小於1,則可得知印刷作業場所中,其經由空氣PAEs暴露所致的危害風險甚低。並由尿液中DBP及DEHP之濃度計算其危害指標,高、低濃度組其HI中位數值皆小於1,以U.S. EPA為參考劑量標準時,尿液中DEHP代謝物總和計算之HI有4位勞工大於1,另外若以EFSA為參考劑量標準時,尿液中DBP代謝物計算之HI有5位勞工大於1,尿液中DEHP代謝物計算則僅有一名勞工其HI值大於1,進一步比較高、低濃度組勞工暴露PAEs之危害指標,則有統計上顯著差異(p<0.0001),顯示高濃度組有較高之PAEs暴露對於勞工所產生的危害風險明顯高於低濃度組。檢測生殖及甲狀腺荷爾蒙濃度之結果,高濃度組男性勞工以尿液中MEOHP及MEHHP中位數濃度分組時,血液中抑制素(Inhinbin B)的濃度皆顯著高於低濃度組(71.3 pg/mL vs. 46.7 pg/mL, p=0.0361 (MEOHP); 70.2 pg/ mL vs. 46.7 pg/mL, p=0.0452 (MEHHP)),其inhibin B濃度過高可能影響體內生殖荷爾蒙平衡,亦以sum of DEHP、MEHP及MEHHP中位數濃度分組時,血液中四碘甲狀腺素(T4)濃度皆顯著低於低濃度組(7.8 μg/dL vs. 9.1 μg/dL, p=0.0459 (sum of DEHP); 7.7 μg/dL vs, 9.1 μg/dL, p=0.0249 (MEHP); 7.8 μg/dL vs. 9.1 μg/dL, p=0.0237 (MEHHP)),以MEHP分組時血液中三碘甲狀腺素(T3)濃度顯著高於低濃度組(116.6 ng/dL vs. 138.4 ng/dL, p=0.0117 (MEHHP)),顯示PAEs之暴露可能會誘導體內荷爾蒙分泌異常。研究發現空氣中PAEs暴露濃度遠低於法定的容許暴露值 (5 mg/m3),亦指出皮膚吸收PAEs可能為印刷作業勞工重要暴露來源,且發現PAEs之暴露可能會影響血液中生殖及甲狀腺荷爾蒙,因此建議勞工PAEs暴露容許值應以生物暴露指標訂定較具代表性。
Phthalate esters (PAEs) were widely added in printing ink as dispersing agent to increase quality of printing products. The aim of this study is to assess the occupational PAEs exposure for workers in printing industry. 20 female and 31 male workers in two printing plants were recruited as subjects. The personal airborne PAEs and urinary PAEs metabolites measurement, blood hormone examination, investigation of personal, occupational exposure data and time activity pattern for all selected workers has been completed. For male workers, the airborne DEHP concentration (0.5 μg/m3 vs 0.3 μg/m3, p<0.05) and urinary MBP level (94.8 μg/g-Cre vs. 67.6 μg/g-Cre, p<0.05) of high-exposure workers (operator, paking) were significantly higher than those of low-exposure workers (officer, patrolling workers). The post- and pre-shift urinary levels of PAEs metabolites of high-exposure male workers shows significant difference: MBP( 94.8μg/g-Cre vs. 66.6μg/g-Cre, p<0.05), MEHP (14.0 μg/g-Cre vs. 5.9 μg/g-Cre, p<0.05), MEOHP (39.0 μg/g-Cre vs. 15.9 μg/g-Cre, p<0.05), MEHHP (85.4 μg/g-Cre vs. 32.7 μg/g-Cre, p<0.05), MECPP (69.7 μg/g-Cre vs. 27.9 μg/g-Cre, p<0.05). The daily intake (DIAir and DIUrine) of PAEs for each worker was calculated with airborne PAEs concentrations and urinary PAEs metabolites levels respectively. The DEHP DIAir (0.03 μg/kg/day vs, 0.02 μg/kg/day, p <0.05) and DBP DIUrine (4.3 μg/kg/day vs 3.0 μg/kg/day, p<0.05) for high-exposure group were significantly higher than low-exposure group. Significant correlation between airborne DEHP concentration and urinary MEOHP (r=0.4930, p<0.05), MECPP (r=0. 5696, p<0.05) were found. Furthermore, the skin absorption of PAEs for workers was estimated. According to the median concentration of PAEs metabolites were classifided to high concentration group and low concentration group. The estimated skin absorption percentiles of DBP and DEHP (DIskin) in high-concentration group were 66.2 % and 63.7 % of DIUrine, respectively. It means the dermal absorption may still as an important potential exposure route for printing workers. Each worker’s Hazard index (HI) which was calculated with airborne PAEs concentrations were all less than 1. The hazard index (HI) of PAEs for each worker was calculated with urinary PAEs metabolites levels. When RfD conducted by USEPA was regarded as reference dose, the calculated hazard index of DEHP for four workers were higher than one. The HI of DBP and DEHP for five and one workers was higher than the TDI set EFSA. For hormone disruption, we found that the Inhinbin B of high-concentration group of male workers were higher than those of low concentration group (71.3 pg/mL vs. 46.7 pg/mL, p=0.0361 (MEOHP); 70.2 pg/ mL vs. 46.7 pg/mL, p=0.0452 (MEHHP)). The T4 of high concentration group of male workers (7.8 μg/dL vs. 9.1 μg/dL, p=0.0459 (sum of DEHP); 7.7 μg/dL vs, 9.1 μg/dL, p=0.0249 (MEHP); 7.8 μg/dL vs. 9.1 μg/dL, p=0.0237 (MEHHP)) and T3 (116.6 ng/dL vs. 138.4 ng/dL, p=0.0117 (MEHHP) were lower than those of low concentration group. We concluded the airborne PAEs concentrations were lower than PEL-TWA (OSHA: 5 mg/m3), although skin absorption of PAEs is important route for printing. The reproductive hormone and thyroid hormone of workers may be disrupted by the PAEs exposure. Therefore, we suggest that the biological exposure index (urinary PAEs metabolites) is more represented the PAEs exposure profile for workers.
Afshari A, Gunnarsen L, Clausen PA, & Hansen V. Emission of phthalates from PVC and other material. Indoor Air. 14: 120–8; 2004.
Agency for Toxic Substance and Disease Registry (US). Toxicological profile for diethyl phthalate (DEP). Atlanta: ATSDR; 1995.
Agency for Toxic Substance and Disease Registry (US). Toxicological profile for di-n-butyl phthalate (DBP). Atlanta: ATSDR; 2001.
Agency for Toxic Substance and Disease Registry (US). Toxicological profile for di-(2-ethylhexyl)phthalate (DEHP). Atlanta: ATSDR; 2002.
Barr DB, Silva MJ, Kato K, Reidy JA, Malek NA, Hurtz D, et al. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environmental Health Perspective. 111: 1148–51, 2003.
Becker K, Seiwert M, Angerer J, Heger W, Koch HM, Nagorka R, et al. DEHP metabolites in urine of children and DEHP in house dust. International Journal of Hygiene and Environmental Health. 207: 409–17, 2004.
Carpenter CP, Weil CS, Smyth HF, Jr. Chronic oral toxicity of di-(2-ethylhexyl) phthalate of rats, guinea pigs, and dogs. American Medical Association Archives of Industrial Hygiene and Occupational Medicine. 8(3): 219-26, 1953.
Carpenter CP, Weil CS, Smyth HF. Chronic oral toxicity of di-(2-ethylhexyl) phthalate of rats, guinea pigs, and dogs. A.M.A. Archives of Industrial Hygiene and Occupational Medicine. 8(3): 219-226, 1953.
Clewell RA, Campbell JL, Ross SM, Gaido KW, Clewell HJ, Andersen ME. Assessing the relevance of in vitro measures of phthalate inhibition of steroidogenesis for in vivo response. Toxicol In Vitro. 24(1):327-34, 2010.
Duty SM., Silva MJ, Barr DB, Brock JW, Ryan L, Chen Z, Herrick RF, Christiani, DC, Hauser R. Phthalate exposure and human semen parameters. Epidemiology. 14: 269–277, 2003.
Duty SM, Ackerman RM, Calafat AM, Hauser R. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environmental Health Perspective. 113: 1530–5, 2005a.
Duty SM, Calafat AM, Silva MJ, Ryan L, Hauser R. Phthalate exposure and reproductive hormones in adult men. Human Reproduction. 20:604-610, 2005b.
EFSA (European Food Safety Authority). Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to Bis(2-ethylhexyl) phthalate (DEHP) for use in food contact materials. EFSA Journal. 243:1–20, 2005a.
EFSA (European Food Safety Authority). Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to di-butylphthalate (DBP) for use in food contact materials. EFSA Journal. 242: 1–17, 2005b.Elsisi AE, Carter DE, Sipes IG. Dermal absorption of phthalate diesters in rats. Fundamental and Applied Toxicology. 12(1): 70-77, 1989.
Ema M, Miyawaki E, Kawashima K. Further evaluation of developmental toxicity of di-n-butyl phthalate following administration during late pregnancy in rats. Toxicol Lett. 98(1-2): 87-93, 1998.
Environmental Protection Agency (US). Di(2-ethylhexyl)phthalate (DEHP) (CASRN 117-81-7): referencedose for chronic oral exposure (RfD). 1991. http://www.epa.gov/iris/subst/0014.htm (accessed Decmber 21, 2010).
Environmental Working Group. Researchers warn consumers about hazardous ingredient in nail polish: Growing scientific concern about dibutyl phthalate (DBP), reproductive age women and links to birth defects. 2000. Retrieved April 14, 2006, from www.ewg.org/ reports/beautysecrets
Environmental Protection Agency (US). Dibutyl phthalate (CASRN 84-74-2): referencedose for chronic oral exposure (RfD). 1990. http://www.epa.gov/iris/subst/0038.htm (accessed Decmber 21, 2010)
Environmental Protection Agency (US). Di(2-ethylhexyl)phthalate (DEHP) (CASRN 117-81-7): referencedose for chronic oral exposure (RfD). 1991. http://www.epa.gov/iris/subst/0014.htm (accessed Decmber 21, 2010).
European Chemical Bureau (Italy). European Union Risk Assessment Report for 1,2-benzenedicarboxylic acid, di-C8-10-branched alkyl esters, C9-rich and di-‘‘isononyl’’ phthalate (DINP) (Final Report 2003). Ispra: ECB; 2003.
European Chemical Bureau (Italy). European Union Risk Assessment Report for Bis(2- ethylhexyl) phthalate (Final Report 2008). Ispra: ECB; 2008.
Foster PMD, Cook MW, Thomas LV, Walters DG, Gangolli SD. Differences in urinary metabolic profile from di-n-butyl phthalte-treated rats and hamsters. Apossible explanation for species differences in susceptibility to testicular atrophy. Drug Metabolism and Disposition. 11: 59-61, 1983.
Fromme H, Gruber L, Schlummer M, Wolz G, Böhmer S, Angerer J, et al. Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based onduplicate diet samples and biomonitoring data. Environment International. 33: 1012–20, 2007.
Frederiksen H, Skakkebaek NE, Andersson AM. Metabolism of phthalates in humans. Molecular Nutrition & Food Research. 51(7): 899-911, 2007.
Fujii M, Shinohara N, Lim A, Otake T, Kumagai K, Yanagisawa Y. A study on emission of phthalate esters from plastic materials using a passive flux sampler. Atmospheric Environment. 37: 5495–504, 2003.
Hagedorn-Leweke U, Lippold BC. Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes. Pharmaceutical Research. 12(9):1354–1360, 1995.
Hakan BT, Westberg, Lennart O, Hardell, Nils Malmqvist, Carl-Goran Ohlson, Olav Axelson. On the Use of Different Measures of Exposure—Experiences from a Case-Control Study on Testicular Cancer and PVC Exposure. Journal of Occupational and Environmental Hygiene 2: 351–356, 2005.
Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. Medications as a source of human exposure to phthalates. Environmental Health Perspective. 112: 751–3, 2004.
Hauser R, Calafat AM. Phthalates and human health. Occupational and Environmental Medicine. 62(11): 806-18, 2005.
Hauser R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, et al. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Human Reproduction. 22: 688–95, 2007.
Hazardous Substances Data Bank, HSDB. http://toxnet.nlm.nih.gov/index.html [accessed 15 February 2011].
Hernández-Díaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates in the US population. Environmental Health Perspective. 117: 185–9, 2009.
Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Human Reproduction. 1–8, 2007.
Huang LP, Lee CC, Hsu PC, Shih TS. The association between semen quality in workers and the concentration of di(2-ethylhexyl) phthalate in polyvinyl chloride pellet plant air. Enviroment and epidemiology Fertility and Sterility. 96(1): 90-94, 2011.
Jäckh R, Rhodes C, Grasso P, Carter JT. Genotoxicity studies on di-(2-ethylhexyl) phthalate and adipate and toxicity studies on di-(2-ethylhexyl) phthalate in the rat and marmoset. Food and Chemical Toxicology. 22(2):151-5, 1984.
Jonsson BA, Richthoff J, Rylander L, Giwercman A, Hagmar L. Urinary phthalate metabolites and biomarkers of reproductive function in young men. Epidemiology. 16(4): 487-493, 2005.
Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isononyl phthalate. Reproductive Toxicology. 16: 679–708, 2002.
Koch HM, Drexler H, Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. International Journal of Hygiene and Environmental Health. 206(2): 77-83, 2003.
Koch HM, Bolt HM, Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Archives of Toxicology. 78(3): 123-130, 2004.
Kohn MC, Parham F, Masten SA, Portier CJ, Shelby MD, Brock JW, et al. Human exposure estimates for phthalates. Environmental Health Perspective. 108: A440–2, 2000.
Koch HM, Muller J, Drexler H, Angerer J. Dibutylphthalate (DBP) in medications: are pregnant women and infants at risk. Umweltmedizin in Forschung und Praxis. 10:144–146, 2005.
Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Archives of Toxicology. 79: 367-76, 2005.
Koch HM, Wittassek M, Angerer J. Influence of alimentary abstinence on body burden to phthalates (Poster). International Conference on environmental epidemiology and exposure (ISEE/ISEA). 2–6, 2006.
Kwapniewski R, Kozaczka S, Hauser R, Silva MJ, Calafat AM, Duty SM. Occupational exposure to dibutyl phthalate among manicurists. Journal of Occupational and Environmental Medicine. 50(6): 705-11, 2008.
Lovekamp-Swan T, Davis B J. Mechanisms of Phthalate Ester Toxicity in the Female Reproductive System. Environmental Health Perspective. 111: 39–145, 2003.
Lee KY, Shibutani M, Takagi H, Kato N, et al. Diverse developmental toxicity of di-n-butyl phthalate in both sexes of rat offspring after maternal exposure during the period from late gestation through lactation, Toxicology. 203:21–238, 2004.
Meeker JD, Calafat AM, Hauser R. Di(2-ethylhexyl) Phthalate Metabolites May Alter Thyroid Hormone Levels in Men. Environmental Health Perspectives. 115:1029–1034, 2007.
Meeker JD, Ferguson KK. Relationship between Urinary Phthalate and Bisphenol A Concentrations and Serum Thyroid Measures in U.S. Adults and Adolescents from NHANES 2007-08. Environmental Health Perspectives. online, 2011.
Occupational Safety & Health Administration (US). Method 104. In: OHSA Sampling and Analytical Methods. Utah: OSHA; 1994.
Occupational Safety and Health Administration (US). Occupational Safety and Health Standards, Toxic and Hazardous Substances. Code of Federal Regulations. 29 CFR 1910.1000. 1998.
Pan G, Hanaok T, Yoshimura M, Zhang S, Wang P, Tsukino H, et al. Decreased serum free testosterone in workers exposed to high levels of (DBP) and (DEHP). Environmental Health Perspectives. 114(11): 1643-8, 2006.
Poon R, Lecavalier P, Mueller R, Valli VE, Procter BG, Chu I. Subchronic oral toxicity of di-n-octyl phthalate and di(2-Ethylhexyl) phthalate in the rat. Food and Chemical Toxicology. 35(2): 225-239, 1997.
Sampson J, de Korte D. DEHP-plasticised PVC: relevance to blood services. Transfusion Medicine. 21: 73-83, 2011.
Shiota K, Chou MJ, Nishimura H. Embryotoxic effects of di-2-ethylhexyl phthalate (DEHP) and di-n-buty phthalate (DBP) in mice. Environmental Research. 22(1):245-53, 1980.
Shiota K, Nishimura H. Teratogenicity of di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBP) in mice. Environmental Health Perspectives.45:65-70, 1982.
Shiota K, Mima S. Assessment of the teratogenicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in mice. Archives of Toxicology. 56(4):263-6, 1985.
Silva MJ, Slakman AR, Reidy JA, Preau JJL, Herbert AR, Samandar E, et al. Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction. Journal of Chromatography B. 805: 161-7, 2004.
Smith CC. Toxicity of butyl stearate, dibutyl sebacate, dibutyl phthalate, and methoxyethyl oleate. A.M.A. Archives of Industrial Hygiene and Occupational Medicine. 7(4): 310-318, 1953.
Wams TJ. Diethylhexylphthalate as an environmental contaminant-a review. Science of the Total Environment 66: 1-16, 1987.
Wester RC, Melendres J, Sedik L, Maibach H, Riviere JE. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicology and Applied Pharmacology. 151(1):159–165, 1998.
Wine RN, Li LH, Barnes LH, Gulati DK, Chapin RE. Reproductive toxicity of di-n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environmental Health Perspectives. 105(1): 102-107, 1997.
Wittassek M, Wiesmuller GA, Koch HM, Eckard R, Dobler L, Muller J, et al. Internal phthalate exposure over the last two decades--a retrospective human biomonitoring study. International Journal of Hygiene and Environmental Health. 210(3-4): 319-333, 2007.
Wolfe GW, Layton KA. Multigeneration reproduction toxicity study in rats: multigenerational reproductive assessment by continuous breeding when administered to Sprague-Dawley rats in the diet. TRC Study No. 7244-200. TherImmune Research Corporation, Gaithersbury, Maryland. 2003.
行政院勞工委員會勞工安全衛生研究所,網版印刷勞工乙二醇乙醚醋酸酯暴露調查,IOSH94-A313,中華民國九十四年。
行政院勞工委員會勞工安全衛生研究所,網版及塑膠印刷業職業衛生輔導技術建立(二) ,IOSH96-A303,中華民國九十六年。
行政院勞工委員會勞工安全衛生研究所,美容業人員鄰苯二甲酸酯類暴露評估研究, IOSH97-A311,中華民國九十七年。
許昺奇、李諭昇,PVC塑膠粒製造業男性勞工生殖危害評估,IOSH98-M306,中華民國九十八年。
李芳錦,PVC塑膠皮布製造及加工作業勞工DEHP之暴露評估研究,成功大學工業衛生暨環境醫學研究所/碩士論文,民國九十九年。
呂怡萱, PVC塑膠粒製造勞工之鄰苯二甲酸酯類暴露評估研究,成功大學工業衛生暨環境醫學研究所/碩士論文,民國九十九年。
吳婉玲,淋浴期間飲水中揮發性致癌物質吸收性健康風險評估,中國醫藥學院 / 環境醫學研究所 / 碩士論文,中華民國九十一年七月。
陳佳飛,食品容器及包裝用塑膠材質之塑化劑溶出研究,國立陽明大學公共衛生系/碩士論文,民國九十一年。
詹秀慧,化妝品銷售鄰苯二甲酸酯類暴露評估研究,國立成功大學/環境醫學研究所 / 碩士論文,中華民國九十四年七月。
謝俊明、林維炤,美容業人員鄰苯二甲酸酯類暴露評估研究,IOSH97-A311,民國九十七年。